Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$25.00
-0.10-0.40%
Pre-Market: 6:45 PM EDT
Comments
Loading...
Beam Therapeutics (BEAM) Forecast
NewsEarningsBeam Therapeutics (BEAM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Beam Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:BEAM | Benzinga
Explore Beam Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BEAM.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Beam Therapeutics (BEAM) stock?
You can purchase shares of Beam Therapeutics (NASDAQ:BEAM) through any online brokerage.
Who are Beam Therapeutics (BEAM) competitors?
Other companies in Beam Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA), Protagonist Therapeutics (NASDAQ:PTGX) and Mesoblast (NASDAQ:MESO).
What is the forecast, or price target, for Beam Therapeutics (BEAM) stock?
Beam Therapeutics has a consensus price target of $56.11.
What is the current price for Beam Therapeutics (BEAM)?
The stock price for Beam Therapeutics (NASDAQ: BEAM) is $25 last updated March 3, 2025 at 6:45 PM EST.
Does Beam Therapeutics (BEAM) pay a dividend?
A quarterly cash dividend of 0.23 per share of Class A Common Stock. The quarterly cash dividend was payable on March 3, 2014 to stockholders of record on February 4, 2014.
When is Beam Therapeutics (NASDAQ:BEAM) reporting earnings?
Beam Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Beam Therapeutics (BEAM) going to split?
There is no upcoming split for Beam Therapeutics.
What sector and industry does Beam Therapeutics (BEAM) operate in?
Beam Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.